Characteristics of fecal and mucosa-associated microbiota in chinese patients with inflammatory bowel disease

Medicine (United States)

Volumn 93, Issue 8, 2014, Pages

  Chen, Liping ^a   Wang, Wei ^a   Zhou, Rui ^a   Ng, Siew C ^b   Li, Jin ^a   Huang, Meifang ^a   Zhou, Feng ^a   Wang, Xin ^c   Shen, Bo ^d   Kamm, Michael A ^e   Wu, Kaichun ^c   Xia, Bing ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d LERNER RESEARCH INSTITUTE   (United States)

^e ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; BUTYRIC ACID DERIVATIVE;

ACIDAMINOCOCCACEAE; ACTINOBACTERIA; ACTINOMYCES; ACTINOMYCETACEAE; ADULT; AGED; ARTICLE; BACTERIUM; BACTEROIDACEAE; BACTEROIDES; BACTEROIDETES; BLAUTIA; BURKHOLDERIACEAE; CHINESE; CHLOROFLEXI; CHRYSEOBACTERIUM; CONTROLLED STUDY; COPROCOCCUS; CROHN DISEASE; DEINOCOCCUS; DELFTIA; ENTEROCOCCACEAE; ENTEROCOCCUS; ERYSIPELOTRICHACEAE; ESCHERICHIA; FAECALIBACTERIUM; FECES MICROFLORA; FEMALE; FIRMICUTES; FLAVOBACTERIACEAE; FUSOBACTERIA; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; INTESTINE BIOPSY; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MICROBIAL COMMUNITY; MIDDLE AGED; NONHUMAN; PATHOGENESIS; PEPTOSTREPTOCOCCACEAE; PREVALENCE; PREVOTELLACEAE; PRIORITY JOURNAL; PROTEOBACTERIA; PYROSEQUENCING; REDUCTION; ROSEBURIA; RUMINOCOCCACEAE; RUMINOCOCCUS; SHIGELLA; SPIROCHETE; STREPTOCOCCACEAE; STREPTOCOCCUS; SYNERGISTETES; THERMUS; ULCERATIVE COLITIS; YOUNG ADULT; ADOLESCENT; ASIAN; DNA SEQUENCE; FECES; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MICROFLORA;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BUTYRATES; COLITIS, ULCERATIVE; CROHN DISEASE; ENTEROCOCCUS; ESCHERICHIA; FECES; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MICROBIOTA; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; SHIGELLA;

EID: 84906077087     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000051     Document Type: Article

References (54)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel disease with time, based on systematic review. Gastroenterology. 2012;142:46-54.
2. Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan City, Central China. Inflamm Bowel Dis. 2006;12:212-217.
3. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel disease. Gastroenterology. 2011;140:1720-1728.
4. Rutgeerts P, Gobes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 1991;338:771-774.
5. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262-267. (Pubitemid 28093532)
6. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620-1633. (Pubitemid 38649878)
7. Selby W, Pavli P, Crotty B, et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology. 2007;132:2313-2319. (Pubitemid 46890859)
8. Feller M, Huwiler K, Schoepfer A, et al. Long-term antibiotic treatment for Crohn's disease: systematic review and meta-analysis of placebo-controlled trials. Clin Infect Dis. 2010;50:473-480.
9. Thia KT, Mahadevan U, Feagan BG, et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2009;15:17-24.
10. Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology. 2004;126:414-424. (Pubitemid 38182298)
11. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-b27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996;98:945-953. (Pubitemid 26293312)
12. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998;66:5224-5231. (Pubitemid 29044613)
13. Garrett WS, Lord GM, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007;131:33-45. (Pubitemid 47505255)
14. Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745-757.
15. Garrett WS, Gallini CA, Yatsunenko T, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 2010;8:292-300.
16. Mylonaki M, Rayment NB, Rampton DS, et al. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:481-487. (Pubitemid 40704083)
17. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54. (Pubitemid 34049193)
18. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scandal J Gastroenterol. 2002;37:1034-1041.
19. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003;52:237-242. (Pubitemid 36115065)
20. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of fecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-211. (Pubitemid 43117279)
21. Soko H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15: 1183-1189.
22. Takaishi H, Matsuki T, Nakazawa A, et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis inflammatory bowel disease. IntJ Med Microbiol. 2008;298:463-472. (Pubitemid 351734793)
23. Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139:1844-1854.
24. Frank DN, Robertson CE, Hamm CM, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:179-184.
25. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis. 2009;15:653-660.
26. PeetersH,Bogaert S,Laukens D, et al.CARD15 variants determine a disturbed early response ofmonocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease. Int J Immunogenet. 2007;34:181-191. (Pubitemid 46763548)
27. Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis. 2012;18:1164-1176.
28. Yamazaki K, Takazoe M, Tanaka T, et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet. 2002;47:469-472. (Pubitemid 34988282)
29. Leong RW, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther. 2003;17:1465-1470. (Pubitemid 36831437)
30. Guo QS, Xia B, Jiang Y, et al. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol. 2004;10: 1069-1071. (Pubitemid 38461397)
31. Fraher MH, O'Toole PW, Quigley EM. Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol. 2012;9:312-322.
32. Ouyang Q, Tandon R, Goh KL, et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J Gastroenterol Hepatol. 2006;21:1772-1782. (Pubitemid 44656996)
33. Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987;92:1894-1898. (Pubitemid 17072238)
34. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
35. Dicksved J, Halfvarson J, Rosenguist M, et al. Molecular analysis of the gut micriobiota identical twins with Crohn's disease. ISME J. 2008;2:716-727. (Pubitemid 351951567)
36. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with inflammatory bowel disease. Gut. 2004;53: 685-693. (Pubitemid 38561447)
37. Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220-230.
38. Ahn J, Sinha R, Pei Z, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst. 2013;105:1907-1911.
39. Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011;128:646-652.
40. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484.
41. Gophna U, Sommerfeld K, Gophna S, et al. Differences between tissue-associated intestinal microbiotas of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol. 2006;44:4136-4141. (Pubitemid 44737260)
42. Walker AW, Sanderson JDD, Churcher C, et al. High-throughput library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011;11:7.
43. Andoh A, Imaeda H, Aomatsu T, et al. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol. 2011;46:479-486.
44. Duncan SH, Louis P, Flint HJ. Cultivable bacterial diversity from the human colon. Lett Appl Microbiol. 2007;44:343-350. (Pubitemid 46496385)
45. Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235-243. (Pubitemid 44309560)
46. Sekirov I, Tam NM, Jogova M, et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immu. 2008;76:4726-4736.
47. Grassl GA, Valdez Y, Bergstrom KSB, et al. Chronic enteric Salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology. 2008;134:768-780.
48. Steck N, Hoffmann M, Sava IG, et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology. 2011;141:959-971.
49. Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol. 2002;160:2253-2257. (Pubitemid 34663415)
50. Papa E, Docktor M, Smillie C, et al. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One. 2012;7:e39242.
51. De Cruz P, Prideaux L, Wagner J, et al. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:372-390.
52. Gevers D, Kugathasan S, Denson LA, et al. The treatment-nave microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15:382-392.
53. Wang W, Chen L, Zhou R, et al. Increased proportion of Bifidobacterium and the Lactobacillus group and loss of butyrateproducing bacteria in inflammatory bowel disease. J Clin Microbiol. 2013;52:398-406.
54. Chen Y, Yang F, Lu H, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011;54:562-572.